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Innovations~~~
Molecular Modeling: An Experimental Tool
The 1920s are sometimes referred to as the
"golden age ofphysics." If recent develop-
ments in several other scientific fields are
any indication, the golden age of physics
may be about to spin offa new golden age
of molecular computer modeling. In its
broadest sense, molecular modeling is the
conjunction ofcomputer technology, crys-
tallography, and theoretical chemistry that
focuses on the properties oflarge biological
molecules.
Technology
Tec4nology is rushing headlong to provide
faster computers by linking many proces-
sors which split thework and avoid, for the
time being, the ultimate limit of how fast
one can move electrons in wires. Similarly,
powerful graphics workstations, the same
ones that render Tyrannosaurus rex believ-
able in current movies, can now make mol-
ecules come alive on a small fluorescent
screen in a biochemistry laboratory. The
same technology makes it possible via the
INTERNET to access, sometimes around
the world, databases of sequences or coor-
dinates ofproteins and nucleic acids. One
database, the Cambridge Database, now
stores the relative atomic positions ofmore
than 110,000 small molecules. Another
database, the Protein Data Bank at Brook-
haven, New York, contains the structures
ofseveral hundred large mol-
ecules. It has recently be-
come the norm for protein
crystallographers to quickly
release data on the coordi-
nates of new structures, re-
versing a long-standing tradi-
tion and providing a boon
forstructural biologists.
Crystallography
Although crystallography
(the art ofextracting molecu-
lar structure from the analy-
sis ofscattered X-rays) got its
start in the golden age of
physics, primarily through
the efforts of the father and
son team of William and
Lawrence BraggatCambridge,
by 1965 only three protein
structures had been solved.
In the 1950s, the essential
foundation of genetics was
provided by Watson and
Crick's correct interpretation Corticosteroni
of the X-ray diffraction data graphic P450c;
from fibrous DNA. Since then, improve-
ments in X-ray devices, including the
sources and detectors, and in the associated
computers and refinement algorithms, have
made it possible to sometimes solve the
structure (i.e., determine the atomic posti-
tions) only weeks after finding a suitable
crystal. The increased availability ofsignifi-
cant quantitites of protein produced with
molecular biology techniques has also had a
major impact. Once the coordinates that
define one structure are determined, variant
proteins can be made using molecular biol-
ogy and their structures can be quickly elu-
cidated, sometimes in a day or two, based
on the primarystructure.
Theoretical Chemistry
The central icon around which theoretical
chemistry clusters is the Schrodinger equa-
tion, THy = Ety. In this equation, His an
operator containing the second derivative
with respect to the postions, iV is the wave
function, and Eis energy. Quantum mech-
anics has as one of its inviolate principles
that the wave fimction (i.e., the solution to
the Schrodinger equation), contains all the
information that can be measured about a
system.
The term "system" refers a part of the
universe that can be controlled for study. If
we think ofthe system as a bio-macromole-
e modeled and energy-minimized into the binding pocket a
am.
cule, along with its environment of other
molecules, then the promise of quantum
mechanics is clear. We need only solve the
Schrodinger equation to know how a mole-
cule will react to stress in vitro or in vivo.
Solving the Schr6dinger equation is the
major challenge before scientists and they
are getting closer. Using these principles, it
may one day be possible to study, for
instance, the dynamics ofa molecular com-
plex important toAIDS.
A major limitation to solving the
Schrodinger equation or its derivative equa-
tions directly is that computer time re-
quirements grow exponentially with the
number of atoms in the system. A new
methodology based not on wave functions,
the traditional solution of the Schrodinger
equation, but on the electron density, is
called density functional theory. This new
approach derives from a theorem stating
that the energy ofa system is a unique func-
tion of the electron density. Density func-
tional theory is still not on quite as firm a
theoretical ground as the conventional
methodology; however, because of its
potential application to verylarge systems, it
is expected to become a method ofchoice.
Gaussian, Inc., a worldwide supplier of
quantum chemical computercode, plans for
its next release to include density functional
theory options.
DrugDesign
The major driving force behind much of
the application of these conver-
gent methodologies is the phar-
maceutical industry and its un-
quenchable thirst for new drugs.
This industry is responsible for
the employment of many scien-
tists with interdisiplinary back-
grounds in fields such as syn-
thetic organic chemistry and
theoretical chemistry. For ex-
ample, in its U.S. operations,
Glaxo has five molecular model-
ers, four protein crystallogra-
phers, four macromolecular nuc-
lear magnetic resonance spectro-
scopists, and a specialist in se-
quence analysis algorithms, with
twice this personnel worldwide.
Several other major pharmaceu-
tical firms have a similar invest-
ment in modeling; in some cases
the investment also includes a
supercomputer such as a CRAY
Y-MP. Much of the research is
built around the knowledge of
Af crystallo- the structure of a key enzyme
and a bound substrate or, more
Environmental Health Perspectiveslikely, a bound inhibitor. Databases and
special docking programs can identify
other compounds likely to fit into the
active-site region. Sometimes new com-
pounds are synthesized to provide a near
perfect fit for delivery ofa specialized func-
tion. More importantly, many more com-
pounds with unknown properties that
might have been synthesized are not
because the theoretical chemistry criteria
(e.g., low space exdusion and complemen-
tary charges between ligand and enzyme)
are not met. Navia and Murko recently
summarized the applications of structural
information, including the related impact
of molecular modeling, in drug design for
hypertension, HIV, emphysema, cancer,
occular hypertension, and coagulation (see
Suggested Reading). A recent example of
the symbiosis between molecular modeling
and directed organic synthesis is the devel-
opment of inhibitors of thymidylate syn-
thase, an essential enzyme for the cellular
production ofDNA, which is thus a target
for anticancerdrugs.
Coincident with the interest of phar-
maceutical firms in using computer tech-
niques to design drugs is the evolution of
software companies, who develop algo-
rithms and new methodologies to find lig-
ands for sites on macromolelcules whose
structures are known. One particulary
impressive product is the DOCK program
developed at the University of California-
San Francisco by Kuntz and co-workers.
Toxicology
Developing more effective drugs is one
obvious use ofthe emerging field ofmolec-
ular modeling. Because drugs and toxic
compounds may be viewed as opposite
sides of the same coin, all the recent
advances in drug development can be
applied in toxicology. Scientists at NIEHS
have used theoretical techniques to help
assimilate a growing body ofexperimental
information derived from molecular biolo-
gy studies of mammalian P450 enzymes.
The NIEHS Laboratory of Reproductive
and Developmental Toxicology has shown
that the mutation of a few amino acids in
mammalian P450 significantly altered the
specificity of the enzyme for its substrate.
A major roadblock to understanding these
results was that the mammalian P450 crys-
tal structure was not yet available. By a
combination ofmolecular modeling, com-
puter graphics, and modified sequence-
analysis algorithms, NIEHS scientists
demonstrated that the mammalian binding
pocket was very likely similar to the bacter-
ial P450 pocket for which a crystal struc-
ture is known, and thus we could better
*understand the specific changes seen in the
molecular biology experiments.
H-raspZl average structure aerivea trom the A-ray structure using tne AMBER program.
Zinc ion modeled intothe active site ortte HIV-1 protease aimer crystal structure.
Dynamics
Many ofthe current techniques forstudying
macromolecules involve static structures.
Howdoes one introduce the timevariable to
study the motion, or dynamics, of macro-
molecular systems? One way is through
Newton's equations of motion. Essentially,
one can solve these equations for the motion
ofall atoms in a molecule ifone knows the
positions and velocities at one snapshot of
time and the potential energy function. This
function defines howthe atoms interactwith
one another. The technology of solving
Newton's equations for molecules is called
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molecular dynamics. To study the motion of
a macromolecule for a significant fraction of
time (i.e., several hundreds of picoseconds)
requires supercomputer-level resources.
Scientists at NIEHS have recently used mol-
ecular dynamics to study several important
enzymatic systems. The ras oncogene prod-
uct p21-H-ras, binds guanosine triphosphate
(GTP) or guanosine diphosphate (GDP).
The active state occurs when GTP is bound,
duringwhich time growth signals are sent to
the cell. In the GDP-bound state the en-
zyme is inactive. By using molecular dynam-
ics with the crystal structure used to define a
starting position, NIEHS scientists showed
that the motion of a hypervariable loop in
p21 may be responsible for the activation of
the key water-cleaving molecule that deacti-
vates the complex. This finding added sup-
port to the crystallographer's speculation
that the dynamics ofthe active site are criti-
cal for enzyme function. Molecular dynam-
ics has also been used to investigate the
HIV-1 protease system. The catalytic pro-
tease of HIV-1 is a dimer, and one of its
functions is to precisely clip the large
polypeptide generated by the virus. The pro
tease is thus a major target of drug design.
Because zinc ions may inhibit the protease,
NIEHS scientists studied where a zinc ion
might be most likely to bind and then
performed molecular dynamics simulations
on the protease with and without the zinc
ion bound (see York et al., EHP 101:
246-250). The zinc-bound molecular
dynamic structure was subsequently used as
the foundation for a quantum mechanical
calculation to predict the molecular details
ofazinc ion bound in the active site.
The Future
The time-dependent Schrodinger equation
provides an analog to Newton's equation of
motion, but unfortunately it is incredibly
difficult to solve, even for small molecules.
Theoreticians are currently searching for
ways to introduce time dependency into
density functional theory so that quantum
dynamics can be performed on large sys-
tems. To date, the dynamics of molecules
consisting of about 100 atoms have been
studied in this way. It is likely that thejuxta-
position of new developments in computer
technology, theoretical chemistry, and crys-
tallography will continue to lead us toward
the day when theoretical calculations on
large molecules are possible. The deeper
understanding of matter that will follow
should motivate many new applications in
molecular science.
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